Publications by authors named "E Segui"

Claim this Profile
E
Endocrine-based strategies after CDK4/6 inhibitors in biomarker-selected subgroup of hormone receptor positive advanced breast cancer: A systematic review and network meta-analysis.
Alicia Escudero, Meritxell Bellet, Cristina Saura, Anna Aguilera, Andri Papakonstantinou

Cancer Treat Rev· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ki67 dynamic predicts endocrine sensitivity in estrogen receptor-positive/HER2-negative breast cancer patients undergoing preoperative endocrine therapy.
R Gómez-Bravo, B Walbaum, M Bergamino, O Martínez-Sáez, F Schettini

ESMO Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic and clinical features in young women with estrogen receptor-positive, HER2-negative breast cancer.
B Walbaum, O Martínez-Sáez, F Brasó-Maristany, E Seguí, N Chic

ESMO Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial.
E Seguí, F Brasó-Maristany, T Pascual, E Sanfeliu, I Victoria

ESMO Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumab.
Rodrigo Sánchez-Bayona, Olga Martínez-Sáez, Denys Romero-Romero, Elia Seguí, Esther Carcelero

NPJ Breast Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis